The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
Open accessAbstract
BACKGROUND: Drugs that selectively inhibit serotonin reuptake are effective treatments for adults with mood and anxiety disorders, but limited data are available on the safety and efficacy of serotonin-reuptake inhibitors in children with anxiety disorders. METHODS: We studied 128 children who were 6 to 17 years of age; who met the criteria for social phobia, separation anxiety disorder, or generalized anxiety disorder; and who had received psychological treatment for three weeks without improvement. The children were randomly assigned to receive fluvoxamine (at a maximum of 300 mg per day) or placebo for eight weeks and were evaluated with rating scales designed to assess the degree of anxiety and impairment. RESULTS: Children in the fluvoxamine group had a mean (+/-SD) decrease of 9.7+/-6.9 points in symptoms of anxiety on the Pediatric Anxiety Rating Scale (range of possible scores, 0 to 25, with higher scores indicating greater anxiety), as compared with a decrease of 3.1+/-4.8 points among children in the placebo group (P<0.001). On the Clinical Global Impressions-Improvement scale, 48 of 63 children in the fluvoxamine group (76 percent) responded to the treatment, as indicated by a score of less than 4, as compared with 19 of 65 children in the placebo group (29 percent, P<0.001). Five children in the fluvoxamine group (8 percent) discontinued treatment because of adverse events, as compared with one child in the placebo group (2 percent). CONCLUSIONS: Fluvoxamine is an effective treatment for children and adolescents with social phobia, separation anxiety disorder, or generalized anxiety disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Despite its positive effects, the use of paroxetine may have caused as side-effects insomnia, decreased appetite, vomiting, withdrawal, agitation, emotional liability and four patients described suicide ideations without attempting to consummate.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In contrast, fluvoxamine is considered effective and well tolerated in the long-term treatment of anxiety disorders with children and adolescents [40].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the fluvoxamine condition drop-out was higher (n = 5) than the placebo group (n = 2) due to sideeffects.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, studies examining the efficacy of fluvoxamine and sertraline have reported a significant reduction in the severity of the anxiety symptoms after only 12 weeks [37,59].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Additional research suggests that combining psychotherapy with pharmacotherapy yields better outcomes than either approach alone, as psychotherapy can teach valuable skills in managing fear-inducing social situations while pharmacotherapy alleviates symptoms facilitating greater participation in behavioral interventions [60,61].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [60]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another study found that 76% of participants treated with fluvoxamine were classified as 'much improved,' compared to 29% in the placebo group [59].”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [59]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The participants allocated to the fluvoxamine experimental group benefited from a significant decrease in anxiety symptoms compared to the participants allocated to the placebo group.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
The cited source says what the claim attributes to it.
In the citing paper
“The most prevalent observed side-effects were headache, abdominal discomfort, increased motor activity and difficulty falling asleep.”
From The risks versus the benefits of pharmacological intervention in social anxiety disorder in children (2025) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
BIRMAHER, B., KHETARPAL, S., BRENT, D., CULLY, M., BALACH, L., KAUFMAN, J., & NEER, S. M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00018 · Cited by 2,846
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity
MARCH, J. S., PARKER, J. D. A., SULLIVAN, K., STALLINGS, P., & CONNERS, C. K. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00019 · Cited by 2,236
Self-citationPine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.56 · Cited by 1,753
Self-citationSHAFFER, D., FISHER, P., DULCAN, M. K., DAVIES, M., PIACENTINI, J., SCHWAB-STONE, M. E., LAHEY, B. B., BOURDON, K., JENSEN, P. S., BIRD, H. R., et al. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199607000-00012 · Cited by 1,587
Self-citationUsers' Guides to the Medical Literature
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.270.21.2598 · Cited by 1,185
Emslie, G. J. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230069010 · Cited by 971
Research works printed but not linked: 3
- Greenhill LL, 1998, Psychopharmacol Bull, 34, 155
- Walkup J, Davies M. The Pediatric Anxiety Rating Scale (PARS): a reliability study. In: Scientific proceedings of the 46th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 19–24, 1999:NR78. abstract.
- Wagner KD, Birmaher B, Carlson G, et al. Multi-center trial of paroxetine and imipramine in the treatment of adolescent depression. In: Scientific proceedings of the 45th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Anaheim, Calif., October 27–November 1, 1998:S12D. abstract.
Cited by
Sorted by citations
Items 401–500 of 589
Anxiety Disorders in Children with Chronic Health Problems
Farrell, L. J., Donovan, C. L., Turner, C. M., & Walker, J. R. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7784-7_32 · Cited by 9
Fox, J. K., & Warner, C. M. (2016) · Child Psychiatry & Human Development · doi:10.1007/s10578-016-0697-5 · Cited by 8
Jurbergs, N., & Ledley, D. R. (2005) · Pediatric Annals · doi:10.3928/0090-4481-20050201-09 · Cited by 8
Mentoring to Facilitate Resiliency in High-Risk Youth
Vance, J. E. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0007 · Cited by 9
Cognitive behavioural therapy for anxiety disorders in children and adolescents
James, A. C., Soler, A., & Weatherall, R. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004690 · Cited by 9
Antidepressant Psychopharmacology and the Social Brain
Novick, A. M. (2011) · Psychiatry · doi:10.1521/psyc.2011.74.1.72 · Cited by 7
Psychiatric Diseases in Children and Adolescents
Cardwell, G. S., Findling, R. L., & Robb, A. S. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_262 · Cited by 7
Nasir, M., Li, F., Courley, S., Olten, B., & Bloch, M. H. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2021.0030 · Cited by 7
Physical Illness And Treatment Of Anxiety Disorders: A Review
Schmidt, N. B., Keough, M. E., Hunter, L. R., & Funk, A. P. (2007) · Springer eBooks · doi:10.1007/978-0-387-74753-8_13 · Cited by 7
Krulewicz, S., Carpenter, D. J., Fong, R., Horrigan, J. P., Lipschitz, A., Perera, P., & Wagner, K. D. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000198593.30702.48 · Cited by 7
Algorithm for the pharmacotherapy of anxiety disorders
Stein, D. J. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0057-6 · Cited by 7
Indications for and use of antidepressants in child and adolescent psychiatry
S�rensen, C. B., Jepsen, E. B., Thomsen, P. H., & Dalsgaard, S. (2003) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-003-0316-4 · Cited by 7
Chapter 50. Treatment of Anxiety Disorders
Choi, S., & Stein, M. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as50 · Cited by 7
Introduction: Assessment of Safety in Pediatric Psychopharmacology
Greenhill, L. L. (2003) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000046843.56865.a5 · Cited by 7
Self-citationExposure therapy and sertraline in social phobia: 1-year follow-up of a randomized controlled trial
Hollander, E., & Samons, D. M. (2003) · Current Psychiatry Reports · doi:10.1007/s11920-003-0053-x · Cited by 7
Beyond 16 Sessions: Extending Manualized Treatment of Anxious Youth
Kagan, E. R., Frank, H. E., Knepley, M. J., & Kendall, P. C. (2021) · Journal of Child and Family Studies · doi:10.1007/s10826-020-01872-5 · Cited by 6
Nature, Assessment, and Treatment of Generalized Anxiety Disorder in Children
Hudson, J. L., Deveney, C., & Taylor, L. K. (2005) · Pediatric Annals · doi:10.3928/0090-4481-20050201-08 · Cited by 6
Riddle, M. A. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200402000-00003 · Cited by 6
Self-citationCoping with Ignorance: Exploring Pharmacologic Management for Pediatric Functional Abdominal Pain
Campo, J. V. (2005) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000189326.65076.65 · Cited by 6
Frölich, J., Lehmkuhl, G., & Döpfner, M. (2010) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.a000002 · Cited by 5
Safety Methodology in Pediatric Psychopharmacology Trials
Yuill, K., & Carandang, C. G. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2011.0142 · Cited by 5
Identification and Treatment of Generalized Anxiety Disorder in Children in Primary Care
Dillon-Naftolin, E. (2016) · Pediatric Annals · doi:10.3928/19382359-20160913-01 · Cited by 6
Angelosante, A. G., Ostrowski, M. A., & Chizkov, R. R. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6599-7_7 · Cited by 6
Treatment of Anxiety Disorders in Children and Adolescents
Hacker, J. L., Picard, L. S., & Strawn, J. R. (2014) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.2014.19.5.1 · Cited by 5
Efficacy of newer antidepressants for childhood anxiety disorders
Masi, G., Millepiedi, S., & Mucci, M. (2002) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2.4.523 · Cited by 6
Angststoornissen bij kinderen en jeugdigen
Koot, H. M., Ferdinand, R. F., & Vlieger-Smid, G. A. (2002) · Kind en adolescent · doi:10.1007/bf03060854 · Cited by 5
Burns, B. J., Compton, S. N., EGGER, H. L., Farmer, E. M. Z., & Robertson, E. B. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0011 · Cited by 5
Self-citationAnxiety Disorders in Children and Adolescents: Assessment and Treatment
Settipani, C. A., Brodman, D. M., Peterman, J. S., Read, K. L., Hoff, A. L., Swan, A. J., & Kendall, P. C. (2014) · Wiley eBooks · doi:10.1002/9781118775349.ch49 · Cited by 5
Leckman, J. F., & YOUNG, C. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200208000-00020 · Cited by 5
What's in a Name? Problems versus Prospects in Current Diagnostic Approaches
Jensen, P. S., Hoagwood, K., & Zitner, L. (2015) · Wiley eBooks · doi:10.1002/9780470939383.ch2 · Cited by 5
Carmin, C. N., & Albano, A. M. (2003) · Professional Psychology Research and Practice · doi:10.1037/0735-7028.34.2.170 · Cited by 5
Zaff, J. F., & Calkins, J. (2001) · Cited by 5
(2017) · doi:10.23970/ahrqepccer192 · Cited by 5
Activation syndrome in children and adolescents treated with selective serotonin reuptake inhibitors
Velasco, D. M. P., & Ospina‐Pinillos, L. (2024) · Revista Colombiana de Psiquiatría (English ed ) · doi:10.1016/j.rcpeng.2022.03.004 · Cited by 4
PSYCHOTROPIC MEDICATIONS: AN UPDATE FOR SCHOOL PSYCHOLOGISTS
Rappaport, N., Kulick, D., & Phelps, L. (2013) · Psychology in the Schools · doi:10.1002/pits.21696 · Cited by 4
Do Hospital and Community SSRI Usage Patterns in Children and Adolescents Match the Evidence?
Ronsley, R. J., Elbe, D., Smith, D. H., & Garland, E. (2010) · PubMed Central · Cited by 4
Normal and pathological anxiety
Emilien, G., Dinan, T. G., Lepola, U. M., & Durlach, C. (2002) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8157-9_1 · Cited by 4
Gentile, S. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.908849 · Cited by 5
Pishva, R. (2017) · Clinical Psychology and Psychotherapy · doi:10.1002/cpp.2046 · Cited by 8
Fahn, S., Jankovic, J. J., & Hallett, M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-2369-4.00016-0 · Cited by 4
Pediatric anxiety and daily fine particulate matter: A longitudinal study
Vancil, A., Strawn, J. R., Rasnick, E., Levine, A. A., Schroeder, H. K., Specht, A. M., Turner, A. L., Ryan, P., & Brokamp, C. (2022) · Psychiatry Research Communications · doi:10.1016/j.psycom.2022.100077 · Cited by 5
Tsujii, T., Sakurai, H., Takeuchi, H., Suzuki, T., Mimura, M., & Uchida, H. (2022) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12299 · Cited by 3
Generalized anxiety disorder in youth
Suveg, C. M., Jacob, M. L., & Thomassin, K. (2009) · Psicología conductual = behavioral psychology: Revista internacional de psicología clínica y de la salud · Cited by 4
Depressão nos adolescentes – mito ou realidade?
Resende, C., Santos, E., Santos, P., & Ferrão, A. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.25753/birth&growthmj.v22.i3.10285 · Cited by 4
Psychopharmacology for Social Anxiety Disorder
Blanco, C., Schneier, F. R., Okuda, M., & Liebowitz, M. R. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375096-9.00019-5 · Cited by 4
Policy Implications Relevant to Implementing Evidence-Based Treatment
English, M. J. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0013 · Cited by 5
Psychopharmacology in the Context of Systems of Care
Pumariega, A. J., Mundo, A. S. D., & Vance, B. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0012 · Cited by 4
Assessing and Treating Social Phobia in Children and Adolescents
Ginsburg, G. S., & Grover, R. L. (2005) · Psychiatric Annals · doi:10.3928/00485713-20050901-06 · Cited by 4
Treatment of depression with selective serotonin inhibitors: the role of fluvoxamine
Pallanti, S., & Sandner, C. (2007) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651500701419685 · Cited by 4
Psychopharmacology of Child and Adolescent Anxiety Disorders
Rosenberg, D. R., Banerjee, S. P., Ivey, J., & Lorch, E. (2003) · Psychiatric Annals · doi:10.3928/0048-5713-20030401-08 · Cited by 4
Selective Serotonin-Reuptake Inhibitors
Rosenberg, D. (2002) · CRC Press eBooks · doi:10.1201/9780203909294.ch9 · Cited by 7
Anxiety Disorders in Children and Adolescents
Vallance, A. K., & Garralda, M. E. (2011) · Wiley eBooks · doi:10.1002/9781119993971.ch27 · Cited by 4
When is it appropriate to treat children with social anxiety, pharmacologically?
Snir, A., Moskow, D. M., & Hofmann, S. G. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1948015 · Cited by 3
The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder
Castagna, P. J., Farahdel, E., Potenza, M. N., & Crowley, M. J. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2199921 · Cited by 3
Zugman, A., Ringlein, G., Finn, E. S., Lewis, K. M., Berman, E., Silverman, W. K., Lebowitz, E. R., Pine, D. S., & Winkler, A. M. (2025) · Psychological Medicine · doi:10.1017/s0033291724003131 · Cited by 3
Self-citationMiller, M., Steuber, E. R., & Mcguire, J. F. (2024) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2024.04.010 · Cited by 4
Byrne, M. E., Haller, S. P., Linke, J. O., Lewis, K. M., Berman, E., Henry, L. M., Pagliaccio, D., Quezada, D., Meyer, M., Abend, R., et al. (2025) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2025.08.010 · Cited by 3
Self-citationAntidepressant Use in a 3- to 12-Year Follow-up of Anxious Youth: Results from the CAMELS Trial
Kagan, E. R., Frank, H. E., Norris, L. A., Palitz, S. A., Chiappini, E. A., Knepley, M. J., Crane, M. E., Phillips, K. E., Ginsburg, G. S., Keeton, C. P., et al. (2020) · Child Psychiatry & Human Development · doi:10.1007/s10578-020-00983-w · Cited by 3
Self-citationMills, J. A., Mendez, E. M., & Strawn, J. R. (2024) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0016 · Cited by 6
Psychopharmakotherapie bei Kindern und Jugendlichen
Mehler‐Wex, C., & Fegert, J. M. (2010) · Springer eBooks · doi:10.1007/978-3-211-85473-0_15 · Cited by 3
Recent NIMH Clinical Trials and Implications for Practice
Kratochvil, C. J., & Vitiello, B. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31818960a7 · Cited by 3
Self-citationMedicated Anxious Children: Characteristics and Cognitive-Behavioural Treatment Response
Liashko, V., & Manassis, K. (2003) · The Canadian Journal of Psychiatry · doi:10.1177/070674370304801106 · Cited by 3
Paroxetine improves social anxiety disorder in children and adolescents
Manassis, K. (2005) · Evidence-Based Mental Health · doi:10.1136/ebmh.8.2.43 · Cited by 3
Prescription d'antidépresseurs chez les enfants et les adolescents
Deniau, E., & Cohen, D. (2011) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(11)45817-x · Cited by 3
Suicidal behaviour in children and adolescents in different clinical settings
Klomek, A. B., Krispin, O., & Apter, A. (2009) · doi:10.1093/med/9780198570059.003.0086 · Cited by 3
Lyneham, H. J., Rapee, R. M., & Schneider, S. (2004) · Springer eBooks · doi:10.1007/978-3-642-18499-4_9 · Cited by 3
Anxiety Disorder in Youth: Separation Anxiety, Social Anxiety, and Generalized Anxiety Disorders
Hughes, M. E., Mohatt, J. W., Bennett, S. M., & Walkup, J. T. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch53 · Cited by 3
Self-citationThe future of pharmacotherapy for paediatric anxiety
Findling, R. L. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.5.573 · Cited by 3
Medicamenteuze behandeling van angststoornissen bij kinderen en adolescenten
Steppe, A. O. P., & Ferdinand, R. F. (2002) · Kind en adolescent · doi:10.1007/bf03060859 · Cited by 3
Read, K. L., Wei, C., Wolk, C. B., Mychailyszyn, M. P., & Kendall, P. C. (2012) · Wiley eBooks · doi:10.1002/9781118315088.ch17 · Cited by 2
The risks versus the benefits of pharmacological intervention in social anxiety disorder in children
Hofmann, S. G., Kasch, C., Pereira, B., Barbosa, C., & Andreoli, G. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2461763 · Cited by 2
Baldes, A., May, T., Brignell, A., & Williams, K. J. (2024) · Child Psychiatry & Human Development · doi:10.1007/s10578-024-01710-5 · Cited by 2
Karawekpanyawong, N., Charnsil, C., Suttajit, S., & Srisurapanont, M. (2025) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000599 · Cited by 2
Ramasamy, S., Jeyaram, K., Narayanan, A., Arunachalam, S., Ethiraj, S., Muthumanickam, S., & Pandian, B. (2024) · In Silico Pharmacology · doi:10.1007/s40203-024-00293-2 · Cited by 2
Counseling and Other Therapeutic Strategies for Children with Asperger Syndrome and Their Families
Wagner, A., & McGrady, K. A. (2003) · Springer eBooks · doi:10.1007/978-1-4419-8883-6_4 · Cited by 2
Korczak, D. J., de pédiatrie, S. C., & du développement, C. D. L. S. M. E. D. T. (2013) · Paediatrics & Child Health · doi:10.1093/pch/18.9.492 · Cited by 2
Bober, J. F., & Preskorn, S. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18500-7_12 · Cited by 2
Attachment, separation, and anxiety disorders
Mulhare, E., Ghesquiere, A., & Shear, M. K. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511777578.022 · Cited by 2
L'utilisation des antidépresseurs aujourd'hui en psychiatrie de l'enfant et de l'adolescent
Lauth, B. (2004) · Perspectives Psy · doi:10.1051/ppsy/2004431034 · Cited by 2
Ansiedad. Depresión y conducta suicida en la adolescencia
Alfageme, M. R., & Guillén, R. H. (2003) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/s0304-5412(03)71137-8 · Cited by 2
Lopes, V. M., & Albano, A. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6599-7_5 · Cited by 2
Psychopharmacology of Pediatric Anxiety Disorders
Mohatt, J. W., Keller, A. E., & Walkup, J. T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6599-7_14 · Cited by 2
Self-citationBernstein, G. A., & Victor, A. M. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_21 · Cited by 2
Integrated Cognitive-Behavior Therapy for Traumatic Stress Symptoms and Substance Abuse
Fairbank, J. A., Booth, S. R., & Curry, J. F. (2002) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195134575.003.0010 · Cited by 2
Kolomeyer, E. G., & Renk, K. (2016) · Clinical Case Studies · doi:10.1177/1534650116668046 · Cited by 2
CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
D'Alli, R. E. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3370-7.00090-0 · Cited by 2
Pharmacologic-Enhanced Approaches for the Anxiety Disorders
Avari, J. M., Cohen, M. G., Hatziergati, D., & Walkup, J. T. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108235655.008 · Cited by 2
Self-citationTaurines, R., Gerlach, M., & Warnke, A. (2016) · Springer eBooks · doi:10.1007/978-3-662-48624-5_5 · Cited by 2
Taurines, R., Warnke, A., Greenhill, L. L., & Gerlach, M. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1501-5_4 · Cited by 2
Self-citationPharmacotherapy for Anxiety Disorders in Children and Adolescents: An Evidence-Based Medicine Review
(2007) · Psychiatric Annals · doi:10.3928/00485713-20070701-05 · Cited by 2
Verhaltenstherapie und psychopharmakologische Behandlung
Steinhausen, H. (2009) · Springer eBooks · doi:10.1007/978-3-540-79545-2_49 · Cited by 2
Psychiatric treatments for children and adolescents preferred by spanish psychiatrists
Toro, J., Mur, M., & Cantó, T. J. (2006) · The European Journal of Psychiatry · doi:10.4321/s0213-61632006000400004 · Cited by 2
Nauta, M. H., & Emmelkamp, P. M. G. (2012) · Wiley eBooks · doi:10.1002/9781118156391.ebcp001017 · Cited by 2
Pharmacotherapy and child psychiatry: is there a way forward?
James, A. C. (2007) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.107.003830 · Cited by 2
Anxiety and Social Relationships in Children and Adolescents
McClure, E. B., & Pine, D. S. (2002) · Child and Adolescent Psychopharmacology News · doi:10.1521/capn.7.6.10.19165 · Cited by 1
Self-citationChapter 60. Treatment of Child and Adolescent Disorders
Wagner, K., & Pliszka, S. R. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as60 · Cited by 1
Psychopharmacology for Pediatric Anxiety Disorders
Ballard, R., Romba, C., & Walkup, J. T. (2024) · Springer eBooks · doi:10.1007/978-3-031-57472-6_14 · Cited by 1
Self-citationPharmacological Treatment for Phobias and Anxiety Disorders
Bloch, M. H., & Mcguire, J. F. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7784-7_23 · Cited by 2
The Development of Targeted Neurobiological Therapies in Child and Adolescent Psychiatry
Vitiello, B., & Grabb, M. C. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.06.002 · Cited by 1
Self-citationConnor, D. F., & Banga, A. (2012) · Journal of Child and Family Studies · doi:10.1007/s10826-012-9613-1 · Cited by 1
Metadata
- Authors
- Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., Davies, M., Sweeney, M., Abikoff, H., Hack, S., Klee, B., McCracken, J., Bergman, L., Piacentini, J., March, J., Compton, S., Robinson, J., O'Hara, T., Baker, S., Vitiello, B., Ritz, L., & Roper, M.
- Affiliations
- New York State Psychiatric Institute (US)
- University of California, Los Angeles (US)
- Duke University (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-04-26
- Volume
- 344
- Issue
- 17
- Pages
- 1279-1285
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2330595721
- Cited by
- 588
- References
- 42
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 18 · 2023: 7 · 2022: 12 · 2021: 14 · 2020: 12 · 2019: 15 · 2018: 10 · 2017: 18 · 2016: 17 · 2015: 19 · 2014: 20 · 2013: 23 · 2012: 23
- FWCI
- 73.53
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Brown University
- Johns Hopkins University
- York University
- National Institutes of Health (n01mh060005-010, n01mh060016-007, n01mh070010-001)
- University of Illinois at Urbana-Champaign
- National Institute of Mental Health (N01 MH 70010, N01 MH60005, N01MH60016)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- fluvoxamine, selective serotonin reuptake inhibitors, childhood anxiety disorders, social anxiety disorder, separation anxiety disorder, generalized anxiety disorder, children and adolescents, drug safety and efficacy, adverse events
- MeSH terms
- Adolescent, Anxiety Disorders, Anxiety, Separation, Child, Female, Humans, Male, Phobic Disorders, Psychotherapy, Anti-Anxiety Agents, Fluvoxamine, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
